H S Cody

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center
    H S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Surg Oncol 8:85-91. 1999
  2. ncbi request reprint Sentinel lymph node biopsy for DCIS: are we approaching consensus?
    Hiram S Cody
    Ann Surg Oncol 14:2179-81. 2007
  3. doi request reprint Clinical significance and management of extra-axillary sentinel lymph nodes: worthwhile or irrelevant?
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
    Surg Oncol Clin N Am 19:507-17. 2010
  4. doi request reprint Axillary management in breast cancer: what's new for 2012?
    Hiram S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, The Weill Medical College of Cornell University, USA
    Breast 21:411-5. 2012
  5. ncbi request reprint Redefining prognosis in node-negative breast cancer: can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy?
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:227S-30S. 2004
  6. ncbi request reprint Point: sentinel lymph node biopsy is indicated for patients with DCIS
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Natl Compr Canc Netw 1:199-206. 2003
  7. ncbi request reprint Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures
    H S Cody
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:13-9. 2001
  8. pmc Clinical aspects of sentinel node biopsy
    H S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, and Cornell University Medical College, New York, New York 10021, USA
    Breast Cancer Res 3:104-8. 2001
  9. ncbi request reprint Current surgical management of breast cancer
    Hiram S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, and Cornell University Medical College, New York 10021, USA
    Curr Opin Obstet Gynecol 14:45-52. 2002
  10. ncbi request reprint Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma
    S K Boolbol
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:20-4. 2001

Collaborators

Detail Information

Publications56

  1. ncbi request reprint State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center
    H S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Surg Oncol 8:85-91. 1999
    ..10% of positive SLN were found by isotope alone, and 11% by dye alone. Failed and false-negative SLN procedures were less frequent as experience increased...
  2. ncbi request reprint Sentinel lymph node biopsy for DCIS: are we approaching consensus?
    Hiram S Cody
    Ann Surg Oncol 14:2179-81. 2007
  3. doi request reprint Clinical significance and management of extra-axillary sentinel lymph nodes: worthwhile or irrelevant?
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
    Surg Oncol Clin N Am 19:507-17. 2010
    ..The greatest future potential for nonaxillary SLNs biopsy is in the management of patients with ipsilateral breast tumor recurrence, where prior axillary surgery may have unpredictably altered the lymphatic drainage of the breast...
  4. doi request reprint Axillary management in breast cancer: what's new for 2012?
    Hiram S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, The Weill Medical College of Cornell University, USA
    Breast 21:411-5. 2012
    ..We review the available evidence on staging and management of the axilla in breast cancer, and outline our interpretation of its implications for clinical practice...
  5. ncbi request reprint Redefining prognosis in node-negative breast cancer: can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy?
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:227S-30S. 2004
    ..By defining more precisely a low-risk cohort of patients, SLN biopsy has the potential to initiate a trend toward medical conservatism as well...
  6. ncbi request reprint Point: sentinel lymph node biopsy is indicated for patients with DCIS
    Hiram S Cody
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Natl Compr Canc Netw 1:199-206. 2003
    ..In DCIS, SLN biopsy may ultimately prove to be a more sensitive screening test for occult invasion than examination of the breast itself...
  7. ncbi request reprint Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures
    H S Cody
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:13-9. 2001
    ..Despite this, few studies examine in detail the factors contributing to the success of these techniques, either individually or in combination...
  8. pmc Clinical aspects of sentinel node biopsy
    H S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, and Cornell University Medical College, New York, New York 10021, USA
    Breast Cancer Res 3:104-8. 2001
    ..Retrospective data suggest that micrometastases identified in this way are prognostically significant, and prospective clinical trials now accruing promise a definitive answer to this issue...
  9. ncbi request reprint Current surgical management of breast cancer
    Hiram S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, and Cornell University Medical College, New York 10021, USA
    Curr Opin Obstet Gynecol 14:45-52. 2002
    ..Prophylactic oophorectomy should be offered to all women with BRCA1-2 mutations, especially those beyond the years of childbearing...
  10. ncbi request reprint Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma
    S K Boolbol
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:20-4. 2001
    ..Further investigation is warranted before this technique is adopted for use in larger breast cancers. Intraoperative examination and biopsy of any suspicious nonsentinel nodes are critical...
  11. ncbi request reprint The breast cancer patient with multiple sentinel nodes: when to stop?
    M D McCarter
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 192:692-7. 2001
    ..A significant minority of patients have 4 or more SLNs. Here we seek to determine the significance for the breast cancer patient of finding multiple SLNs, and whether there is an optimal threshold number of SLNs that should be removed...
  12. ncbi request reprint Highest isotope count does not predict sentinel node positivity in all breast cancer patients
    R C Martin
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:592-7. 2001
    ..Having removed the SLN with the highest counts, how far should the surgeon persist in removing additional SLN which contain much lower levels of isotope?..
  13. ncbi request reprint Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection
    M D McCarter
    The Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:682-6. 2001
    ..CONCLUSIONS: The results of SLN mapping with same-day and day-before injection of radioisotope are virtually identical. The logistical advantages of day-before injection do not compromise the success of the procedure...
  14. pmc Have changing treatment patterns affected outcome for operable breast cancer? Ten-year follow-up in 1288 patients, 1965 to 1978
    H S Cody
    Department of Surgery, St Luke s Roosevelt Hospital Center, New York, New York
    Ann Surg 213:297-307. 1991
    ..As the primary surgical treatment of breast cancer continues to become more moderate, the promise of systemic adjuvant therapies can be realized only with continued emphasis on earlier diagnosis and maximal local control of disease...
  15. ncbi request reprint Internal mammary node status: a major prognosticator in axillary node-negative breast cancer
    H S Cody
    Department of Surgery, New York Hospital Cornell Medical Center, New York
    Ann Surg Oncol 2:32-7. 1995
    ..Systemic adjuvant therapy should be considered for T1N0 patients with central or medial tumors...
  16. ncbi request reprint Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer
    R C Martin
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 130:432-8. 2001
    ..The dermal and parenchymal lymphatics of the breast drain to the same axillary SLN in most breast cancer patients, and ID isotope injection is the procedure of choice in this setting...
  17. ncbi request reprint Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    M R Weiser
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:145-9. 2001
    ..CONCLUSION: Patients with small breast cancers, no LVI, and SLN micrometastases have a low risk of non-SLN metastases, and may not require completion ALND...
  18. ncbi request reprint A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer
    J L B Bevilacqua
    Department of Surgery and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur J Surg Oncol 28:603-14. 2002
    ..Based on our review, we propose an algorithm for a selective approach to IM-SLN in breast cancer...
  19. ncbi request reprint Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer
    L Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 177:887-91. 2001
    ..CONCLUSION: Percutaneous imaging-guided large-core breast biopsy and sentinel lymphadenectomy provide a minimally invasive approach to the diagnosis and treatment of women with nonpalpable invasive breast cancers...
  20. ncbi request reprint Sentinel lymph node biopsy in patients with male breast carcinoma
    E R Port
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 91:319-23. 2001
    ..SLNB is aimed at preventing these morbidities. In this study, the authors evaluated the role of SLNB in the treatment of men with early stage breast carcinoma...
  21. ncbi request reprint Pleomorphic adenoma of the breast: case report and review of the literature
    P Iyengar
    Department of Pathology, Breast Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Diagn Cytopathol 33:416-20. 2005
    ..Correct identification of this benign mammary neoplasm is important to avoid unnecessarily aggressive treatment...
  22. ncbi request reprint Axillary node staging for microinvasive breast cancer: Is it justified?
    J M Lyons
    Memorial Sloan Kettering Cancer Center, New York, NY
    J Clin Oncol 29:7. 2011
    ..Here we report clinical characteristics and outcome in 112 patients with DCISM, with a particular focus on the role of sentinel lymph node (SLN) biopsy...
  23. ncbi request reprint ErbB-2 protein in sera and tumors of breast cancer patients
    B Breuer
    The Strang Cancer Prevention Center, New York, New York 10021, USA
    Breast Cancer Res Treat 49:261-70. 1998
    ..In women who were over the age of 50 years the trend was reversed; i.e., levels of erbB-2 tended to be lowest in Group III, followed by Group II, and finally Group I...
  24. ncbi request reprint Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Ann Surg Oncol 14:2209-14. 2007
    ..The question then arises: How best to manage the axilla in the setting of LR after previous BCT and SLN biopsy or axillary dissection (ALND)?..
  25. ncbi request reprint Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter?
    Mary Jo Wright
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 204:541-9. 2007
    ..The purpose of this study was to compare the incidence of positive margins and rates of reexcision between two methods of margin assessment at a single institution...
  26. pmc A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram
    Julia Park
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 245:462-8. 2007
    ....
  27. ncbi request reprint One-step surgery for breast cancer: back to the future?
    Hiram S Cody
    World J Surg 31:1153-4. 2007
  28. ncbi request reprint Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions
    Hiram S Cody
    J Surg Oncol 95:440-2. 2007
  29. ncbi request reprint Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation
    José Luiz B Bevilacqua
    Department of Surgery, Memorial Sloan Kettering Cancer Center, MRI 1026, New York, NY 10021, USA
    J Clin Oncol 25:3670-9. 2007
    ..We developed a user-friendly prediction model (nomogram) based on a large data set to assist in predicting the presence of SLN metastasis...
  30. ncbi request reprint Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy
    Sarah A McLaughlin
    Department of Breast Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:76-82. 2008
    ..The purpose of this study was to determine if eliminating FS would change reoperation rates in BCT patients...
  31. ncbi request reprint Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?
    Sharon Wing Wai Chan
    Department of Surgery, United Christian Hospital, Kowloon, Hong Kong, China
    Ann Surg 247:143-9. 2008
    ....
  32. doi request reprint MRI identifies otherwise occult disease in select patients with Paget disease of the nipple
    Mary Morrogh
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:316-21. 2008
    ..The purpose of this study was to evaluate the role of breast MRI in this setting...
  33. doi request reprint Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up
    Lee K Tan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 26:1803-9. 2008
    ..However, there is no consensus regarding the optimal method for pathologic examination of SLN, or the prognostic significance of SLN micrometastases...
  34. doi request reprint Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients
    Mark L Kayton
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 112:2052-9. 2008
    ..Few data exist regarding techniques, indications, and outcomes for sentinel lymph node biopsy in pediatric patients with sarcomas and carcinomas...
  35. doi request reprint Sentinel lymph node biopsy is successful and accurate in male breast carcinoma
    Laurie W Flynn
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:616-21. 2008
    ..Sentinel lymph node (SLN) biopsy minimizes this risk. We report results from the largest series of SLN biopsies for male breast cancer and compare this experience with that of female counterparts treated concurrently...
  36. doi request reprint Reoperative sentinel lymph node biopsy after previous mastectomy
    Amer Karam
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 207:543-8. 2008
    ..Here we describe our experience with reoperative-SLN (re-SLN) biopsy after previous mastectomy...
  37. ncbi request reprint Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma
    Elisa Rush Port
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 195:167-72. 2002
    ..Although previous breast or axillary surgery is often considered a contraindication to SLN biopsy, few data support this position. We report our experience with SLN biopsy in the reoperative setting...
  38. ncbi request reprint Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women
    Larissa K F Temple
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 9:654-62. 2002
    ..We prospectively compared the sensory morbidity and lymphedema experienced after sentinel node biopsy (SLNB) and axillary dissection (ALND) over a 12-month period by using a validated instrument...
  39. ncbi request reprint Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer
    Leslie L Montgomery
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Anesth Analg 95:385-8, table of contents. 2002
    ..In addition, our data indicate that patients with a sulfa allergy do not display a cross-sensitivity to isosulfan blue dye...
  40. ncbi request reprint Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 101:926-33. 2004
    ..In the current study, we address this question by examining the pattern of SLN involvement in patients undergoing prophylactic mastectomy (PM) at Memorial Sloan-Kettering Cancer Center (New York, NY)...
  41. ncbi request reprint Sentinel lymph node biopsy for breast cancer: does anybody not need one?
    Hiram S Cody
    Ann Surg Oncol 10:1131-2. 2003
  42. ncbi request reprint A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    Kimberly J Van Zee
    Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 10:1140-51. 2003
    ..Accurate estimates of the likelihood of additional disease in the axilla could assist greatly in decision-making regarding further treatment...
  43. ncbi request reprint Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
    Katrina H Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 100:929-34. 2004
    ....
  44. ncbi request reprint The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers
    Eleni Tousimis
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 197:529-35. 2003
    ..Multicentric (MC) and multifocal (MF) invasive breast cancers are considered to be relative contraindications to SLNB. We examine the accuracy of SLNB in patients with MC and MF invasive breast cancers...
  45. ncbi request reprint A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer
    Tari A King
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 11:535-41. 2004
    ..This study examined whether the volume of isosulfan blue dye used in sentinel lymph node (SLN) mapping in breast cancer is related to the SLN identification rate or to the incidence of allergic reactions...
  46. ncbi request reprint Missed micrometastatic disease in breast cancer
    May Lynn Quan
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 31:311-7. 2004
    ..A major challenge for future investigations will be to determine if SLN and bone marrow micrometastases represent similar or distinct biologic phenomena, and whether this distinction will have any implications for treatment...
  47. ncbi request reprint Don't give up your gamma probe
    Elisa R Port
    Ann Surg Oncol 11:813-4. 2004
  48. pmc The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures
    Arpana M Naik
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 240:462-8; discussion 468-71. 2004
    ..We sought to identify the rate of axillary recurrence after sentinel lymph node (SLN) biopsy for breast cancer...
  49. ncbi request reprint Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer
    Anna M Derossis
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 197:896-901. 2003
    ..Increasing body mass with age has an inverse relationship to success. A proportion of SLN biopsy patients are both senior and overweight, so measurement of the body mass to age relationship is essential...
  50. ncbi request reprint Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Michelle C Specht
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Am Coll Surg 200:10-4. 2005
    ..Here we report the results of SLN biopsy in a selected group of breast cancer patients with palpable axillary nodes classified as either moderately or highly suspicious for metastasis...
  51. ncbi request reprint The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients
    Edi Brogi
    Department of Pathology, Breast Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 12:173-80. 2005
    ..The goal of intraoperative sentinel lymph node (SLN) examination is to avoid reoperation for a positive SLN, but the ideal method of intraoperative SLN examination remains unclear, and published results vary widely...
  52. ncbi request reprint American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer
    Gary H Lyman
    University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    J Clin Oncol 23:7703-20. 2005
    ..To develop a guideline for the use of sentinel node biopsy (SNB) in early stage breast cancer...
  53. ncbi request reprint Sentinel lymph node drainage in multicentric breast cancers
    Hong Jin Kim
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Breast J 8:356-61. 2002
    ..However, further studies are needed to validate the accuracy of SLN biopsy in multicentric breast cancers...
  54. pmc Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer
    Hiram S Cody
    Ann Surg 244:324; author reply 324-5. 2006
  55. ncbi request reprint The sentinel node concept: a critique of the critique
    Hiram S Cody
    Breast 15:571-4. 2006
  56. ncbi request reprint Breast cancer in the previously augmented breast
    Colleen M McCarthy
    Department of Surgery, Plastic and Reconstructive Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Plast Reconstr Surg 119:49-58. 2007
    ..This article explores the oncologic and reconstructive issues relevant to women desiring cosmetic breast implants and women with breast cancer who have undergone prior cosmetic breast augmentation...